Assignee
SHENZHEN TURIER BIOTECH CO LTD
CN·2 granted patents·4 pending applications·2 citations·filing 2016–2021
Top patents by PatentIndex Score
6 records- 0164US11419918B2Treatment of biliary cirrhosis based on oxyntomodulin analogue GLP-1R/GCGR dual-target agonist peptideSHENZHEN TURIER BIOTECH CO LTD·Filed 2018·Granted Aug 23, 2022·1 cites·11 claims
- 0263US11197914B2GLP-1R/GCGR dual target agonist polypeptide for treatment of fatty liver diseases, hyperlipemia and arteriosclerosisSHENZHEN TURIER BIOTECH CO LTD·Filed 2016·Granted Dec 14, 2021·1 cites·9 claims
- 0352US2024174728A1A use of a polypeptide compound in the preparation of drugs for preventing or treating inflammatory bowel diseases and related intestinal fibrosisSHENZHEN TURIER BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 0450US2023364194A1GLP-1R/GCGR Dual Target Agonist Polypeptide Derivative for Treatment of Hepatic Fibrosis Associated with Viral HepatitisSHENZHEN TURIER BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 0548US2024336653A1Peptide compound targeting elastin-derived peptides and use thereofSHENZHEN TURIER BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 0645US2023183310A1Polypeptide Compounds and Use Thereof in the Prevention or Treatment of Diabetes or Diabetic ComplicationsSHENZHEN TURIER BIOTECH CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHENZHEN TURIER BIOTECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →